Orexins and Orexin Receptors in Metabolic Syndrome Research

Introduction: The Metabolic-Hypothalamic Axis

Metabolic syndrome (MetS) is no longer viewed merely as a collection of peripheral symptoms but as a systemic failure of energy homeostasis. It is defined by a cluster of interconnected pathologies: central obesity, insulin resistance, dyslipidemia, and systemic hypertension. Collectively, these factors exponentially increase the risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD).

Traditionally, research focused on peripheral hormones like insulin and leptin. However, the paradigm has shifted toward the Central Nervous System (CNS) as the "master regulator." Among the various neuropeptide systems, the Orexin (Hypocretin) system has emerged as a quintessential bridge. It provides the neural circuitry required to coordinate behavioral arousal with peripheral metabolic demands, positioning it as a primary target for translational metabolic research.

Orexin as a Glucose and Nutrient Sensor

Orexin neurons function as highly specialized metabolic sensors capable of detecting fluctuations in nutrient availability and circulating glucose concentrations. This allows the hypothalamus to dynamically coordinate behavioral and metabolic responses according to systemic energy status.

Under fasting or low-glucose conditions, orexin neuronal activity increases significantly, promoting wakefulness, food-seeking behavior, and energy mobilization. In contrast, elevated glucose levels suppress orexin neuronal firing, establishing a direct physiological connection between nutrient availability and hypothalamic signaling.

In addition to glucose sensing, orexin neurons integrate signals from several major metabolic hormones, including:

• Ghrelin
• Leptin
• Insulin

Ghrelin activates orexin signaling during energy deficiency, whereas leptin and insulin suppress orexin activity under nutrient-rich conditions. Through this endocrine integration, the orexin system acts as a central coordinator of feeding behavior, metabolic activity, and energy expenditure.

Thermogenesis and Brown Adipose Tissue

Brown adipose tissue (BAT) plays a key role in adaptive thermogenesis and systemic energy expenditure. Unlike white adipose tissue, which primarily stores energy, BAT dissipates energy as heat through mitochondrial activity. Increasing evidence suggests that orexin signaling contributes directly to BAT activation and thermogenic regulation, linking the orexin pathway to obesity and metabolic syndrome.

BAT Activation

Orexin neurons regulate BAT activity through hypothalamic-autonomic pathways that connect the central nervous system with peripheral adipose tissues. Activation of orexin signaling enhances sympathetic stimulation of BAT, increases mitochondrial activity, and promotes energy expenditure. Reduced orexin activity is associated with impaired thermogenesis and increased susceptibility to obesity.

UCP1 Regulation

A major mediator of orexin-induced thermogenesis is UCP1 (uncoupling protein 1), a mitochondrial protein highly expressed in brown adipocytes. Orexin signaling promotes UCP1 expression and thermogenic gene activation, allowing energy to be released as heat rather than stored as ATP.

WAT Browning

In addition to activating BAT, orexin signaling may promote the browning of white adipose tissue (WAT), generating beige adipocytes with thermogenic properties. This process is associated with increased mitochondrial density, enhanced fatty acid oxidation, and elevated energy expenditure, making it an important mechanism in metabolic syndrome research.

Fig. 2 Central actions of orexins/hypocretins on food intake and BAT thermogenesis

Sleep-Wake-Metabolism Axis

The orexin system is a major regulator of wakefulness and arousal stability, forming an important biological bridge between sleep physiology and metabolic regulation.

Loss of orexin-producing neurons is the hallmark of Narcolepsy Type 1, a neurological disorder frequently associated with increased body weight, reduced basal metabolic rate, and metabolic abnormalities despite normal caloric intake. These clinical observations provide strong evidence linking orexin deficiency with impaired metabolic homeostasis.

Circadian rhythm disruption and chronic sleep deprivation further contribute to metabolic dysfunction through orexin-dependent pathways. Reduced orexin signaling has been associated with:

• Increased appetite
• Weight gain
• Reduced insulin sensitivity
• Impaired glucose metabolism
• Elevated metabolic syndrome risk

These findings highlight the close physiological relationship between sleep regulation, circadian biology, and energy metabolism.

Conclusion

Orexin signaling represents a master integration point where the brain's perception of the environment meets the body's metabolic reality. By coordinating wakefulness with energy expenditure, glucose disposal, and thermogenesis, orexins act as a natural defense mechanism against the development of Metabolic Syndrome.

As we advance our understanding of the OX1R/OX2R pathways, the orexin system stands as a beacon of hope for next-generation pharmacological interventions that treat obesity and diabetes not just as peripheral diseases, but as disorders of central energy management.